Genexine Inc - ESG Rating & Company Profile powered by AI
Other corporations in the rating peer group for Genexine Inc are displayed below. This ESG rating includes 17 United Nations SDGs including: 'Good Health & Wellbeing', 'Industry, Innovation & Infrastructure' and 'Life on Land'. If you are employed by Genexine Inc and you wish to use your ESG rating, please contact us.
Genexine Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Genexine Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Genexine Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Genexine Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Genexine Inc report the average age of the workforce?
Sign up for free to unlockDoes Genexine Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Genexine Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Genexine Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Genexine Inc offer flexible work?
Sign up for free to unlockDoes Genexine Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Genexine Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Genexine Inc conduct supply chain audits?
Sign up for free to unlockDoes Genexine Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Genexine Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Genexine Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Genexine Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Genexine Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Genexine Inc disclose water use targets?
Sign up for free to unlockDoes Genexine Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Genexine Inc have a product recall in the last two years?
Sign up for free to unlockDoes Genexine Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Genexine Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Genexine Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Genexine Inc disclose parental leave metrics?
Sign up for free to unlockDoes Genexine Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Genexine Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Genexine Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Genexine Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Genexine Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Genexine Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Genexine Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Genexine Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Genexine Inc disclose its waste policy?
Sign up for free to unlockDoes Genexine Inc report according to TCFD requirements?
Sign up for free to unlockDoes Genexine Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Genexine Inc disclose energy use targets?
Sign up for free to unlockDoes Genexine Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Genexine Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Genexine Inc
These potential risks are based on the size, segment and geographies of the company.
Genexine, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of immunotherapeutics and long-acting biologics in South Korea. It develops hyFc platform, a proprietary technology designed to drive the discovery of various differentiated agonistic protein therapeutics; and the Immune Enhancing Technology, a therapeutic DNA vaccine technology. The company's product pipeline includes GX-H9, which is in Phase II clinical trials for the treatment of adult and pediatric growth hormone deficiency; GX-E2, which is in Phase II clinical trials for the treatment of induced anemia; GX-G3, which is in Phase II clinical trials to treat neutropenia; and GX-G6 that is in Phase I clinical trials for the treatment of diabetes. It is also developing GX-188E that is in Phase II clinical trials in combination with KEYTRUDA for the treatment of cervical cancer. Genexine, Inc. has a co-development partnership with Binex Co. Ltd. to develop COVID-19 vaccine. The company was formerly known as Genexine Co., Ltd. and changed its name to Genexine, Inc. in March 2013. Genexine, Inc. was founded in 1999 and is based in Seongnam, South Korea.